Nemaura Medical (NSDQ:NMRD) announced today that it is planning to immediately repurpose its SugarBeat continuous glucose monitor (CGM) as a continuous temperature monitor (CTM) to help diagnose fevers in potential cases of COVID-19.
The Loughborough, England-based company said in a news release that its inbuilt temperature sensor is capable of continuously tracking body temperature through the skin, which can potentially help in the battle against coronavirus. Google’s Verily recently announced plans to develop a small body-worn temperature patch that transmits data to a phone application to notify users of fever and support the early diagnosis of viral infections.
Get the full story at our sister site, Drug Delivery Business News.